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H I G H L I G H T S
• Cu-containing MBGs (Cu-MBG) syn-
thesised as micro and nanospheres.
• Cu-MBGs incorporated into an in-
jectable polyurethane hydrogel.
• Sustained and prolonged release of
Cu2+ ions from incorporated Cu-
MBGs.
• Hybrid injectable formulations for in
situ delivery of therapeutic ions.
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A B S T R A C T
Copper-containing bioactive glasses (Cu-MBGs) are attracting increasing interest as multifunctional agents for
hard and soft tissue healing due to the ability of released copper ions to stimulate osteogenesis as well as
angiogenesis and to impart anti-bacterial properties. The conjugation of these nanomaterials with a vehicle
phase based on thermosensitive hydrogels represents an effective strategy to design non-invasive injectable
devices for the in situ delivery of therapeutic ions from MBGs.
In this contribution, Cu-containing MBGs were prepared by an aerosol-assisted spray-drying method (MBG_Cu
2%_SD) in the form of microspheres (surface area of ca 220m2 g−1) and through a sol-gel synthesis (MBG_Cu 2%
_SG) in the form of spheroidal nanoparticles (surface area above 700m2 g−1). Both Cu-containing samples were
able to release copper ions, although with different rates and percentage release. MBG_Cu 2%_SG released the
total incorporated amount of Cu ions with a faster kinetics compared to MBG_Cu 2%_SD, that released ap-
proximately the 60% of copper.
Cu-MBGs were incorporated with a final concentration of 20mg/mL into a thermosensitive sol-gel system
consisting of a novel amphiphilic poly(ether urethane) based on a commercialy available Poloxamer 407 (P407),
with improved gelation ability, mechanical strength and stability in aqueous solution with respect to native
P407. Cu-MBG-loaded hydrogels were characterised in terms of sol-to-gel transition temperature and time, in-
jectability and stability in aqueous environment at 37 °C. The hybrid formulations showed fast gelation in
physiological conditions (1 mL underwent complete sol-to-gel transition within 3–5min at 37 °C) and inject-
ability in a wide range of temperatures (5–37 °C) through different needles (inner diameter in the range
0.6–1.6mm).
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When embedded into the hydrogel, Cu-MBGs retained their release properties, showing a sustained delivery
of Cu2+ along 14 days.
1. Introduction
The use of organized mesoporous materials continues to gain in-
terest in a wide range of biomedical applications due to their ability to
store and release drugs/biomolecules and to the possibility to impart
stimuli-responsive and/or targeting properties through surface func-
tionalization [1–3].
In the field of advanced bioceramics, templated mesoporous glasses,
which combine the textural features of ordered mesoporous matrices,
i.e. very high exposed surface area and pore volume, with the properties
of conventional bioactive sol-gel glasses, have shown excellent beha-
viour as systems for bone-tissue regeneration [4–6]. More recently, with
the aim to develop a smart and versatile technology platform for highly
targeted therapies for pathological tissues (hard and soft), the compo-
sition of mesoporous bioactive glasses (MBGs), conventionally synthe-
sized in the systems SiO2-CaO or SiO2-CaO-P2O5, has been enriched
with controlled amount of therapeutic elements, as Ag+, Sr2+, Cu2+
and Co2+, whose release is able to impart specific biological functions,
including anti-bacterial activity, as well as stimulation of osteogenesis
and angiogenesis [7–11]. In particular, several studies have extensively
proven the ability of released copper ions to enhance bone regeneration
and vascularization, as well as wound healing [12,13]. Very recently,
Wu and co-workers finely demonstrated the role of Cu2+ ions released
from mesoporous silica nanospheres in inducing osteogenic/angiogenic
response while suppressing osteo-clastogenic activity [14]. The sus-
tained release of copper ions from MBGs can also act as an effective
anti-microbial agent against both bacterial growth and biofilm forma-
tion/dispersion, providing a true alternative to traditional antibiotic
systemic therapies [15]. Furthermore, the release of therapeutic ions
can be synergistically combined with the delivery of pharmaceutical
agents or growth factors incorporated into the internal cavities or ad-
sorbed/grafted on the external surface.
The resulting multifunctional nanocarriers are ideal candidates for
the development of novel clinical devices able to simultaneously
target all the causes, often mutually interlocked, leading to compro-
mised tissue healing. To this aim, the conjugation of these carriers with
a vehicle phase based on thermosensitive hydrogels, in which an aqu-
eous solution undergoes a sol to gel transition in physiological condi-
tions (37 °C), represents an effective strategy to design non-invasive
devices that can be injected into the pathological site and, after gelling
in situ, will result in an ion/drug depot for prolonged and localised
release. Recently, the feasibility of this approach has been proven for
the preparation of an anticancer depot system based on thermosensitive
Pluronic F127 hydrogel carrying doxorubicin-loaded mesoporous silica
nanoparticles [16]. Pluronic F127, also coded as Poloxamer 407, is a
poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-
PPO-PEO) triblock copolymer extensively used in biomedical applica-
tions [17]. However, Pluronic F127-based hydrogels suffer of poor
stability in aqueous environment, starting to dissolve few minutes after
injection and thus do not allow a prolonged and sustained release
overtime [18,19]. One of the most commonly investigated approaches
to overcome this limitation consists in chain extending Pluronic F127
through the chemistry of polyurethanes (PURs), which, amongst other
things, also allows the introduction of specific moieties for further
functionalization, targeted degradation or specific cell behaviour along
the polymer backbone. As a consequence of the high chemical versa-
tility that characterizes this class of polymeric materials, a wide range
of PUR compositions has been designed and thoroughly investigated for
different applications in the fields of regenerative medicine and phar-
maceutics, ranging from implantable biostable devices to biodegradable
scaffolds and delivery systems [18–27]. Hence, PURs act as a flexible
platform of materials able to fit the requirements imposed by the final
application. In particular, PUR composition can be opportunely selected
based on the required mechanical properties of the resulting PUR-based
device: rigid polyurethane scaffolds are suitable for bone tissue re-
placement [28–30], while soft polyurethane constructs better fit with
the regeneration of soft tissues (i.e. cardiac, vascular and nerve tissues)
[25,31,32].
For some applications, such as filling of restricted, non load bearing
defect sites, injectable PUR-based hydrogels, able to perfectly take the
shape of the defect cavity prior to their complete gelation, have been
successfully developed to allow easy administration and minimally in-
vasive injection [33].
In this regard, Boffito et al. [18] recently reported the synthesis of a
novel amphiphilic poly(ether urethane) (PEU) based on Poloxamer 407,
with improved gelation ability, mechanical strength and stability
compared to the commercially available Poloxamer 407, showing
promising features for application in tissue engineering/regenerative
medicine and drug release as in situ injectable delivery systems. In the
literature, injectable PURs developed for bone tissue engineering have
been conjugated with an inorganic phase, such as tricalcium phosphate
or mineralized bone particles, with the aim to improve the mechanical
properties and confer osteoconductivity to the final hybrid constructs
[31,34].
In this study, with the aim to prepare an injectable hybrid for-
mulation able to release in situ therapeutic ions from MBG particles, a
Poloxamer 407-based PEU has been synthesized according to a pre-
viously published method [20] and its aqueous solutions have been
loaded with MBGs belonging to the SiO2-CaO-CuO system to design a
hybrid thermosensitive MBG-PEU platform.
Copper-containing MBGs have been prepared in the form of micro-
and nano-spheres by following two synthesis approaches in order to
evaluate the effect of particle size and size distribution on the resulting
formulation properties. The obtained MBG-PEU systems have been in-
vestigated in terms of sol-to-gel transition temperatures and time, in-
jectability and stability in aqueous environment at 37 °C to mimic the
real working conditions of the developed systems. The release profiles
of Cu2+ ions from the glass matrices alone and upon loading into the
hydrogel have been assessed and the obtained kinetics compared.
2. Materials and methods
2.1. Preparation of Cu-containing MBGs
Copper-loaded MBGs were prepared through two different synthesis
approaches in order to obtain particles with different size and structural
parameters (i.e. specific surface area, pore size).
2.1.1. Preparation of Cu-containing MBG nanoparticles by sol-gel synthesis
The first procedure is a base-catalysed sol-gel synthesis, as reported
by Wu et al. [35] to produce mesoporous calcium-silicate nanoparticles,
where copper replaces part of calcium. In particular, MBG with 2%
molar percentage of Cu (molar ratio Cu/Ca/Si= 2/13/85, named
hereafter as MBG_Cu 2%_SG) was prepared as follows: 6.6 g cetyl-
trimethylammonium bromide (CTAB≥ 98%, Sigma Aldrich, Italy) and
12mL NH4OH (Ammonium hydroxide solution, Sigma Aldrich, Italy)
were dissolved in 600mL of double distilled water (ddH2O) under
stirring for 30min. Then, 30mL tetraethyl orthosilicate (TEOS, Tetra-
ethyl orthosilicate, Sigma Aldrich, Italy), 4.888 g of calcium nitrate
tetrahydrate (Ca(NO3)2·4H2O, 99%, Sigma Aldrich, Italy) and 0.428 g of
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copper chloride (CuCl2 99%, Sigma Aldrich, Italy) were added under
vigorous stirring for 3 h. The powder was collected by centrifugation
(Hermle Labortechnik Z326) at 10,000 rpm for 5min, washed one time
with distilled water and two times with absolute ethanol. The final
precipitate was dried at 70 °C for 12 h and calcined at 600 °C in air for
5 h at a heating rate of 1 °Cmin−1 using a Carbolite 1300 CWF 15/5, in
order to remove remaining traces of CTAB.
2.1.2. Preparation of Cu-containing MBG microspheres by aerosol-spray-
assisted approach
MBG microspheres with 2% molar percentage of Cu (molar ratio
Cu/Ca/Si= 2/13/85, hereafter named as MBG_Cu 2%_SD) were syn-
thesized by modifying a spray-drying method reported by Pontiroli
et al. [36]. Briefly, 2.030 g of the non-ionic block copolymer Pluronic
P123 (EO20PO70EO20, average Mn ∼5800 Da, Sigma Aldrich, Italy)
were dissolved in 85 g of ddH2O. In a separate batch, a solution of
10.73 g of TEOS was pre-hydrolysed under acidic conditions using 5 g
of an aqueous HCl solution at pH 2 until a transparent solution was
obtained. The solution with TEOS was then poured drop by drop into
the template solution and kept stirring for 1 h. Then, 0.163 g of copper
chloride (CuCl2 99%, Sigma Aldrich, Italy) and 1.86 g of calcium nitrate
tetrahydrate (Ca(NO3)2 4H2O, 99%, Sigma Aldrich, Italy) were added.
The final solution was stirred for 15min and then sprayed (Büchi,
Mini Spray-Dryer B-290) using nitrogen as the atomizing gas with the
following parameters: inlet temperature 220 °C, N2 pressure 60mmHg
and feed rate 5mL/min. The obtained powder was finally calcined at
600 °C in air for 5 h at a heating rate of 1 °Cmin−1 using a Carbolite
1300 CWF 15/5.
2.2. Cu-containing MBG characterization
2.2.1. Physico-chemical characterization of Cu-MBGs
The morphology of MBG particles was analyzed by Field-Emission
Scanning Electron Microscopy (FE-SEM) using a ZEISS MERLIN in-
strument. For FE-SEM observations, 10 mg of MBG_Cu 2%_SG powder
was dispersed in 10mL of isopropanol using an ultrasonic bath (Digitec
DT 103H, Bandelin) for 5min to obtain a stable suspension. 5 μL of the
resulting suspension was dropped on a carbon coated copper grid
(3.05 mm Diam.200 MESH, TAAB) and successively coated with Cr
layer for FE-SEM and EDS mapping analysis.
MBG_Cu 2%_SD powder was dispersed on a conductive carbon tape
and coated with Cr layer. Compositional analysis of the powders was
performed by energy dispersive spectroscopy (EDS; AZtec EDS, Oxford
instruments).
EDS spectra were collected on powders dispersed on carbon tape by
analysing an area of 75×50 μm. The samples were characterized by
wide-angle (2ϑ within 10–80°) X-ray diffraction (XRD, X’Pert PRO,
PANalytical). Nitrogen adsorption-desorption isotherms were measured
at -196 °C using an ASAP2020, Micromeritics. Samples were outgassed
at 150 °C for 5 h before analysis. The Brunauer-Emmett-Teller (BET)
equation was used to calculate the specific surface area (SSABET) from
the adsorption data (relative pressures 0.04–0.2). The pore size dis-
tribution was evaluated through the DFT method (Density Functional
Theory) using the NLDFT kernel of equilibrium isotherms (desorption
branch).
2.2.2. In vitro bioactivity test
Cu-containing MBG bioactivity was assessed by soaking 30mg in
30mL of simulated body fluid (SBF), as reported in the literature [37].
The samples were kept immersed at 37 °C up to 14 days, inside an or-
bital shaker Excella E24, Eppendorf, with an agitation rate of 150 rpm.
At each time point (1 day, 7 days and 14 days) the powders were se-
parated by centrifugation at 5000 rpm for 5min, washed with distilled
water and dried in oven at 70° C for 12 h. Hydroxyapatite formation
was assessed by FESEM/EDS and wide-angle (2ϑ within 10–80°) X-ray
diffraction (XRD, X’Pert PRO, PANalytical).
2.2.3. Evaluation of Cu ion release from Cu-containing MBG particles
In order to evaluate Cu ion release, MBG_Cu 2%_SG and MBG_Cu 2%
_SD samples were suspended in Tris HCl buffer (Tris(hydroxymethyl)
aminomethane (Trizma) (Sigma Aldrich, Italy) 0.1 M, pH 7.4) at a final
concentration of 250 μg/mL, according to the protocol described by Shi
et al. [14]. Specifically, 5 mg of the samples were kept immersed in
20mL of buffer up to 14 days at 37 °C in an orbital shaker Excella E24,
Eppendorf with an agitation rate of 150 rpm. At each predefined time
point (3 h, 24 h, 3 days, 7 days and 14 days) the suspensions were
centrifuged for 5min at 10.000 rpm (Hermle Labortechnik Z326), half
of the supernatant was collected and replaced by the same amount of
fresh buffer. Each experiment was carried out in triplicate and results
are reported and mean ± standard deviation. The concentration of Cu
ions was measured by Inductively Coupled Plasma Atomic Emission
Spectrometry Technique (ICP-AES) (ICP-MS, Thermoscientific, ICAP
Q), after appropriate dilutions.
2.3. Synthesis of Poloxamer-based poly(ether urethane)
2.3.1. Materials
Poloxamer 407 (P407) (PEO-PPO-PEO triblock copolymer,
Mn=12,600 Da, 70% w/w PEO), 1,6-hexamethylene diisocyanate
(HDI), dibutyltin dilaurate (DBTDL) and 1,4-cyclohexanedimethanol
(CDM) were purchased from Sigma Aldrich (Italy). Before use, with the
final aim of removing residual water from the reagents, P407 was dried
under reduced pressure at 100 °C for 8 h and then cooled down at 40 °C
under vacuum, HDI was distilled under reduced pressure and CDM was
kept at room temperature under vacuum in a desiccator. Anhydrous 1–2
dichloroethane (DCE) was prepared by pouring the solvent over acti-
vated molecular sieves (3 Å, Sigma Aldrich, Italy) under nitrogen at-
mosphere overnight. All solvents were purchased from Sigma Aldrich
(Italy) in analytical grade.
2.3.2. Synthesis protocol
P407-based PEU was synthesized via a two-step procedure in ni-
trogen atmosphere, according to the protocol recently published by
Boffito et al. [18]. Briefly, P407 was first solubilized in DCE at 20% w/v
concentration and equilibrated at 80 °C. HDI was then added at
2:1 molar ratio with respect to P407 and the prepolymerization reaction
proceeded for 2.5 h after addition of catalytic amount of DBTDL (0.1%
w/w with respect to P407). At the end of the first step, the reaction
mixture was equilibrated at 60 °C and the isocyanate-terminated pre-
polymer was chain extended by adding CDM (3% w/v in DCE) at
1:1 molar ratio with respect to P407. After 1.5 h, the system was cooled
down at room temperature and anhydrous methanol was added to stop
the reaction. The polymer was then collected by precipitation in pet-
roleum ether (4:1 vol ratio with respect to DCE reaction volume) and
purified by dissolution in DCE at 20% w/v followed by precipitation in
a mixture of diethyl ether and methanol (98:2 v:v) at 5:1 vol ratio with
respect to DCE. Finally, the polymer was collected by centrifugation
(Hettich, MIKRO 220R) at 0 °C, 6000 rpm for 20min, and dried over-
night at room temperature under a fume hood.
Hereafter, the synthesized PEU will be referred to as CHP407, where
C identifies the chain extender 1,4-cyclohexanedimethanol, H stands
for 1,6-hexamethylene diisocyanate and P407 refers to the macrodiol
Poloxamer 407.
2.4. Chemical characterization of CHP407
2.4.1. Attenuated Total Reflectance Fourier Transform Infrared (ATR-
FTIR) Spectroscopy
Both P407 and CHP407 were characterized by Attenuated Total
Reflectance Fourier Transform Infrared (ATR-FTIR) Spectroscopy using
a Perkin Elmer Spectrum 100 equipped with an ATR accessory (UATR
KRSS) with diamond crystal. The spectra resulted from 16 scans in the
spectral range from 4000 to 600 cm−1 with a resolution of 4 cm−1. The
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analysis were conducted at room temperature and analyzed using the
Perkin Elmer Spectrum software.
2.4.2. Size Exclusion Chromatography (SEC)
CHP407 molecular weight distribution was evaluated through an
Agilent Technologies 1200 Series (CA, USA) Size Exclusion
Chromatography (SEC) equipped with a Refractive Index (RI) detector
and two Waters Styragel columns (HR2 and HR4) conditioned at 35 °C,
and using tetrahydrofuran (THF, CHROMASOLV Plus, inhibitor-free,
for HPLC, 99.9%, Sigma Aldrich, Italy) as mobile phase. Number
average molecular weight (Mn) and polydispersity index (D) were
measured starting from a calibration curve based on polystyrene stan-
dards with peak molecular weight (Mp) in the range 740–180,000 Da
using the Agilent ChemStation software. Before analysis, CHP407
powder was dissolved in THF at 2mg/mL concentration and filtered
through a 0.45 μm syringe filter (Whatman).
2.5. Preparation of CHP407-based hydrogels loaded with Cu-MBGs
MBG_Cu 2%_SG and MBG_Cu 2%_SD were loaded in CHP407-based
hydrogel with a final particle and PEU concentration of 20mg/mL and
15% w/v, respectively. PEU concentration was kept at 15% w/v based
on our previously published data on the behaviour of aqueous solutions
of a PEU with similar building blocks [18]. In order to load CHP407-
based hydrogels, a Cu-MBG suspension was first prepared at 100mg/
mL concentration and sonicated (Sonics, Vibracells) with a 20% am-
plitude for 3min to improve particle dispersion. Subsequently, a pre-
defined volume of particle suspension was added to CHP407-based
solutions previously prepared at higher concentration to reach at the
end the requested PEU and particle concentration in the hydrogel.
CHP407-based solutions were prepared by powder solubilisation in
physiological saline solution (0.9% NaCl) at 5 °C overnight to avoid
micellization and/or gelation phenomena that would prevent complete
polymer dissolution. For the same reason, particle suspension addition
was conducted in a water bath maintained at 5 °C. Each sample was
mixed with a Vortex stirrer (Argo LAB Mix) for 30 s to homogeneously
disperse the particles inside the hydrogel and stored in the gel state in
an incubator (Memmert IF75) at 37 °C to avoid potential particle se-
dimentation. Before any characterization requiring the system in the sol
state, the gels were put in a water bath at 5 °C for 3min to allow the gel-
to-sol transition. Hereafter, CHP407-based sol-gel systems loaded with
Cu-MBG particles will be referred to with the acronym CHP407_15%w/
v_WW, where WW identifies the Cu-MBG synthesis route (SD or SG).
Sol-gel systems not-loaded with mesoporous particles were also pre-
pared and used as control (acronym CHP407_15%w/v).
2.6. Characterization of CHP407-based hydrogels
2.6.1. Tube inverting test
Tube inverting test was carried out to qualitatively determine the
sol-to-gel transition temperature. Each sol-gel system (1mL) was pre-
pared in a sample container (Savatec, Italy) with an inner diameter of
17 mm according to the previously described protocol and subjected to
a step-by-step temperature increase within the range 5–70 °C. In each
step, the samples were subjected to a temperature increase of
1 ± 0.1 °C, followed by temperature maintenance for 5min and in-
version for 30 s for the visual inspection of the sample sol/gel state.
Conditions of sol and gel were defined as “flow liquid sol” and “no flow
solid gel” within the 30 s of inversion, respectively.
2.6.2. Gelation time at 37 °C
Gelation time tests were conducted to establish the requested time
to reach a complete transition from the sol to the gel state in physio-
logical conditions, i.e. at 37 °C. Samples (1 mL) were prepared in
sample containers (Savatec, Italy) with an inner diameter of 17mm
according to the previously described protocol and incubated in an
incubator (Memmert IF75) previously equilibrated at 37 °C. At pre-
defined time points of 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10min the samples
were inverted for 30 s for the visual inspection of their sol/gel state.
Conditions of sol and gel were defined as in the tube inverting test. At
each time point, the samples were equilibrated at 4 °C for 8min before
incubation at 37 °C to ensure that all the systems were in the sol state at
the beginning of the test.
2.6.3. Hydrogel injectability
Injectability of CHP407-based sol-gel systems loaded with Cu-MBG
particles was tested using a 5mL plastic syringe through three needles
differing for their internal diameter, G22 (diameter 0.64mm), G18
(diameter 1.02mm) and G14 (diameter 1.63mm). Injectability was
tested at three different temperatures (5, 25 and 37 °C) by three po-
tential users. Before the test, the sol-gel systems were left at each tested
temperature for 25min to reach thermal stability and system equili-
bration in the sol, biphasic or gel state.
2.6.4. Hydrogel stability and swelling
Swelling and stability tests were carried out on CHP407-based hy-
drogels (2 mL) not-loaded and loaded with MBG_Cu 2%_SD and
MBG_Cu 2%_SG particles. The prepared samples were weighed (Wi) and
incubated at 37 °C for 15min to allow the complete transition from the
sol to the gel state before the beginning of the test. After gelation, 2 mL
of Tris HCl buffer solution previously equilibrated at 37 °C were added
to each sample. At predefined time steps (3h, 24 h, 3 days, 7 days,
14 days) three samples were taken from the incubator and weighted
(Wf) once removed the residual buffer to quantify their absorption
ability (Swelling%), while the incubation medium of all other samples
incubated at 37 °C was refreshed with Tris HCl (equilibrated at 37 °C
prior to addition). Then, the samples were freeze-dried (Martin Christ
ALPHA 2–4 LSC, Germany) and weighted again (Wfreeze-dried_f) to in-
vestigate their weight loss (Weight loss%). Control samples (not in-
cubated in buffer solutions) were also freeze-dried and weighed (Wfreeze
dried_i). Buffer absorption and system stability were estimated according
to the following equations:
=
−
×Swelling% (w w )
w
100f i
f (1)
=
−
×
− −
−
Weight loss% (w w )
w
100freeze driedi freeze driedf
freeze driedi (2)
Results are reported as mean ± standard deviation.
At each time point, the morphology of the freeze-dried CHP407
hydrogels loaded with both MBG_Cu 2%_SD and MBG_Cu 2%_SG par-
ticles was analyzed by FE-SEM microscopy using a Philips 525M in-
strument.
2.6.5. Evaluation of Cu ion release from CHP407 hydrogels loaded with Cu-
MBGs
Cu ion release was evaluated from CHP407 hydrogels (2 mL) loaded
with both MBG_Cu 2%_SD and MBG_Cu 2%_SG particles. The prepared
samples were first incubated at 37 °C for 15min to allow the complete
transition from the sol to the gel state before the beginning of the test.
After gelation, 2 mL of Tris HCl previously equilibrated at 37 °C were
added to each sample. At predefined time steps (3h, 24 h, 3 days,
7 days, 14 days) the supernatant was refreshed, while the collected
volume was centrifuged for 15min at 6.000 rpm (Hettich, MIKRO
220R) and analyzed by ICP-AES after appropriate dilutions to measure
the concentration of released Cu ions. Analyses were conducted in tri-
plicate and results are reported as mean ± standard deviation.
2.7. Statistical analysis
Statistical analysis was performed using GraphPad Prism version
5.00 for Windows (GraphPad Software, La Jolla, CA, USA;
C. Pontremoli et al. Chemical Engineering Journal 340 (2018) 103–113
106
www.graphpad.com). Two-way ANOVA analysis followed by
Bonferroni’s multiple comparison test was used to compare results. The
statistical significance of each comparison was assessed as reported by
Boffito et al. [18].
3. Results and discussion
3.1. Cu-MBG characterization
3.1.1. Morphological and structural characterization
FE-SEM images of MBG_Cu 2%_SG (Fig. 1A) showed particles with a
uniform spherical morphology, with size ranging between 150 and
200 nm. EDS mapping analysis revealed a homogeneous distribution of
silicon (yellow) and calcium (red) throughout the analyzed particles
(Fig. 1B), at variance the analysis of copper was not reliable due to
presence of the element in the sample holder. EDS spectrum of the
powder dispersed on carbon tape (Fig. 1C) confirmed the incorporation
of copper inside the framework, with a Cu/Si molar ratio (as average of
three measurements) in fair agreement with the nominal ratio.
MBG_Cu 2%_SD, as shown in Fig. 2A, consists of microspheres with
size mostly in the range of 1–5 μm, showing silicon (yellow), calcium
(green) and copper (light blue) homogeneously distributed into the
framework, as revealed by the compositional mapping EDS analysis
carried out on a single sphere (Fig. 2B). EDS spectrum of the powder
supported on the carbon-based tape revealed the incorporation of
copper with a molar concentration very close to the nominal ratio
(Fig. 2C).
Wide-angle XRD (Fig. S1) confirmed that copper did not form seg-
regated oxide clusters after calcination treatment, as assessed by the
absence of crystalline oxide-based phases.
The N2 adsorption-desorption isotherms confirmed the mesoporous
structure of both copper-containing MBGs (Fig. 3A). The type IV iso-
therm curve of MBG_Cu 2%_SG showed a well-defined step around 0.4
(P/P0), indicative of the filling of uniform mesopores. Related DFT pore
size distribution (Fig. 3B) confirmed the presence of uniform mesopores
with a mean diameter centred at around 4 nm. The BET specific surface
area (SSA) and pore volume (reported in Table 1) resulted remarkably
high, slightly lower than those reported for similar systems without
copper [38].
The isotherm of the sample obtained by aerosol-assisted procedure
also confirmed its mesoporous structure. The isotherm (Fig. 3C) is a IV
type curve, with H1 hysteresis loop, typical of mesoporous material
with pores larger than 4 nm. The pore size distribution showed multi-
sized pores with broad distribution, ranging between 8 and 11 nm
(Fig. 3D). The specific surface area of MBG_Cu 2%_SD, although lower
than the one shown by MBG_Cu 2%_SG, is still very high compared to
values typical of not-templated sol-gel glasses (few m2 g−1), which
confers an high reactivity to MBGs in the biological environment [5].
3.1.2. Bioactive behaviour of Cu_MBGs
The remarkable bioactivity of MBG_Cu 2%_SG and MBG_Cu 2%_SD
when soaked in SBF was clearly revealed by FE-SEM observations. After
only 1 day of soaking, the particles started to be covered by a rough
layer of globular agglomerates of Ca-deficient hydroxyapatite (HA)
phase (Ca/P=1.51), as shown by EDS analysis (data not shown). After
14 days, MBG particles were almost fully covered by a compact layer of
needle-like nanocrystals, composed by calcium and phosphorus. Fig. 4
shows MBG_Cu 2%_SD after soaking for 14 days. EDS analysis per-
formed on powders evidenced a Ca/P ratio of 1.7, typical of hydro-
xyapatite [39,40].
XRD analysis performed on the MBG particles after the bioactivity
test confirmed the formation of crystalline hydroxyapatite: marked
peaks appeared at 25.68° and 31.99° (2ϑ value) and other less intense
reflections at 39.85°, 46.53° and 49.36° (2ϑ value) matched by hydro-
xyapatite reference (00-001-1008).
3.1.3. Copper ion release from Cu-MBGs
The ionic concentration (ppm) of Cu2+ species from MBG_Cu 2%_SG
powder in Tris HCl medium is reported in Fig. 5: almost the total
amount of incorporated copper was released within the first 3 h of in-
cubation with a final released concentration of about 4.7 ppm. On the
other hand, the release profile from MBG_Cu 2%_SD particles showed a
less pronounced burst effect in the first 3 h compared to MBG_Cu 2%
_SG, followed by a sustained release of copper ions overtime. The ob-
served release kinetics suggested that the diffusion of Cu2+ out of the
mesopores is probably hindered or even blocked after the first hours
(2–3 h) of incubation. A similar release profile has been already ob-
served from silica-based mesoporous spheres [41] and was ascribed to
the progressive occlusion of mesopores due to the dissolution of the
silica framework and its re-precipitation as silica gel at the pores mouth
[42,43]. The final concentration of released copper species from
MBG_Cu 2%_SD was about 2.5 ppm, lower than that found for MBG_Cu
2%_SG, and corresponding to approximately the 60% of incorporated
copper, suggesting the presence of a residual amount of copper into the
MBG framework or re-precipitation phenomena. The faster ion release
kinetics shown for MBG_Cu 2%_SG particles can be ascribed to the re-
markably higher surface area and the lower particle size (short diffusion
paths), which allow fast ion diffusion inside the porous structure. Fur-
thermore, as MBG_Cu 2%_SD particles are produced by an aerosol-as-
sisted spray-drying process, where a rapid evaporation of the solvent
takes place, the resulting powder is expected to show a less condensed
framework compared to MBG_Cu 2%_SG and thus much higher re-
activity toward surface dissolution/re-precipitation reactions.
3.2. Chemical characterization of CHP407
The success of CHP407 synthesis was assessed by ATR-FTIR spec-
troscopy, as shown in Fig. 6, which compares the ATR-FTIR spectra of
the starting Poloxamer 407 and the as synthesized CHP407 poly(ether
urethane).
Fig. 1. A) FE-SEM image of MBG_Cu 2%_SG. B) EDS mapping analysis of MBG_Cu 2%_SG.
C) EDS spectrum of MBG_Cu 2%_SG (analyzed area of 75× 50 μm).
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The analysis of CHP407 ATR-FTIR spectrum proved the successful
synthesis of a poly(ether urethane) containing Poloxamer 407 building
blocks, as demonstrated by the presence of the absorption peaks at
2880 and 1099 cm−1, that can be ascribed to the stretching vibration of
CH2 and C–O–C groups, respectively. The successful synthesis of
CHP407 was assessed by the appearance of new bands that can be as-
cribed to the formation of urethane bonds. In detail, the peaks at 1720
and 1530 cm−1 can be attributed to the stretching vibration of carbonyl
groups (C]O) (amide I) and the bending vibration of NeH bonds
(amide II), respectively. The newly formed urethane and amide groups
also showed absorption at 3341 cm−1, ascribed to NeH stretching. The
absence of an absorption peak at 2200 cm−1 due to unreacted diiso-
cyanates proved the complete conversion of the monomers.
Polyurethane average numeral molecular weight (Mn) obtained by
SEC was in the range of 50,000–60,000 Da. The low polydispersity
index (D) of the polyurethane (1.3) indicates a narrow distribution of
the molecular weight and thus a good control over the polymerization
process.
3.3. Characterization of CHP407 hydrogels loaded with Cu-MBGs
MBG_Cu 2%_SG and MBG_Cu 2%_SD particles were loaded in 15%
Fig. 2. A) FE-SEM image of MBG_Cu 2%_SD. B) EDS mapping analysis of MBG_Cu 2%_SD single particle. C) EDS spectrum of MBG_Cu 2%_SD (analyzed area of 75×50 μm).
Fig. 3. A) N2 adsorption-desorption isotherm of MBG_Cu 2%_SG. B) DFT pore size distribution of MBG_Cu 2%_SG. C) N2 adsorption-desorption isotherm of MBG_Cu 2%_SD. D) DFT pore
size distribution of MBG_Cu 2%_SD.
Table 1
Structural features of MBG_Cu 2%_SG and MBG_Cu 2%_SD.
Samples SSABET (m2 g−1) Pore Volume
(cm3 g−1)
DFT Pore Size (nm)
MBG_Cu 2%_SG 740 0.15 4
MBG_Cu 2%_SD 226 0.05 8–11 nm
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w/v concentrated CHP407 aqueous solutions at a final concentration of
20mg/mL. The newly designed hybrid injectable systems were char-
acterized in terms of their thermosensitivity and gelation kinetics, in-
jectability, stability and swelling in physiological conditions, and Cu2+
ion release kinetics.
3.3.1. Lower critical gelation temperature and gelation time in physiological
conditions
Tube inverting and gelation time tests allowed the investigation of
the effects of particle loading on the gelation of CHP407-based sol-gel
systems. Fig. 7 reports Lower Critical Gelation Temperature (LCGT)
values and gelation time in physiological conditions (37 °C) of
CHP407_15%w/v sol-gel systems loaded and not-loaded with both
MBG_Cu 2%_SG and MBG_Cu 2%_SD at 20mg/mL concentration.
Irrespective of the type of incorporated particles (SG or SD), LCGT
values tended to slighly increase upon Cu-MBG loading in the hybrid
sol-gel systems (27 °C for CHP407_15%w/v, 29 °C for both
CHP407_15%w/v_SD and CHP407_15%w/v_SG). This behaviour sug-
gests that, most likely, mesoporous particles hinder or slow down the
kinetics of micelle formation and packing into a fully developed gel
with increasing temperature. Similarly to the not-loaded control sample
(CHP407_15%w/v), loaded sol-gel systems did not show a gel-to-sol
transition up to 70 °C. The trend of gelation time at 37 °C was opposite
to that observed for LCGTs. In fact, gelation time at 37 °C slighly de-
creased upon Cu-MBG particles loading, irrespective of the synthesis
route used to prepare them (from 5min for CHP407_15%w/v to 3 and
4min for CHP407_15%w/v_SG and CHP407_15%w/v_SD, respectively).
The decrease in gelation time in physiological conditions can be cor-
related to an increase in the viscosity of the systems upon particle in-
corporation, as typical of colloidal systems. Although the kinetics of gel
formation and development slow down, as suggested by the tube in-
verting test results, an increase in the viscosity of the systems can ac-
count for a decrease in gelation time in isothermal conditions, being the
conditions of sol and gel defined as “flow liquid sol” and “no flow solid
gel” within 30 s of tube inversion, respectively. For what concerns the
Fig. 4. FE-SEM of MBG_Cu 2%_SD after 14 day of soaking in SBF (A) and high magnification of A image (B).
Fig. 5. Cu2+ release profiles in Tris HCl from MBG_Cu 2%_SG and MBG_Cu 2%_SD.
Fig. 6. ATR-FTIR spectra of Poloxamer 407 (red) and the as synthesized CHP407 poly
(ether urethane) (blue). Differences between the spectra that prove the success of the
synthesis process are highlighted in blue, while the typical peaks of P407 are evidenced in
red. (For interpretation of the references to colour in this figure legend, the reader is
referred to the web version of this article.)
Fig. 7. Lower critical gelation temperature (LCGT) values (black) and gelation time in
physiological conditions (37 °C) (grey) of CHP407_15%w/v and CHP407 sol-gel systems
with 15% w/v PEU concentration loaded with MBG_Cu 2%_SG and MBG_Cu 2%_SD
particles at 20mg/mL (CHP407_15%w/v_SG and CHP407_15%w/v_SD) obtained by tube
inverting test. Error: ± 0.5 °C for LCGT values, ± 30 s for gelation time values.
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influence of particle type on gelation time in physiological conditions,
MBG_Cu 2%_SG-loaded hydrogels exhibited a faster gelation than
MBG_Cu 2%_SD-loaded systems. This behaviour can be correlated to the
different size and size distribution of MBG_Cu 2%_SG compared to
MBG_Cu 2%_SD. As MBG_Cu 2%_SG particles show smaller particle size
and narrower size distribution, on equal suspension concentration,
higher amount of particles and better dispersion inside CHP407-based
hydrogel is expected compared to MBG_Cu 2%_SD, thus inducing a
higher viscosity of the final hybrid formulation.
3.3.2. Qualitative evaluation of hydrogel injectability
MBG_Cu 2%_SG- and MBG_Cu 2%_SD-loaded CHP407 sol-gel sys-
tems with 15% w/v PEU concentration and 20mg/mL particle content
were characterized in terms of their injectability at different tempera-
tures (5, 25 and 37 °C) through different needles (G22, G18, G14)
(Table 2).
At 5 °C, all the prepared samples were in the sol phase and easy
injectable through all needles. With increasing temperature, irrespec-
tive of the presence of Cu-MBG particles, all CHP407 (15%w/v) solu-
tions underwent a transition from the sol to the gel state. As a con-
sequence of this transition, viscosity increased leading to the
impossibility to inject the gels through G22 needle at both 25 and 37 °C.
On the contrary, all the samples turned out to be still injectable through
the largest tested needle, i.e. G14. For what concerns G18 needle, the
gel CHP407 (15%w/v) loaded with MBG_Cu 2%_SG was not injectable
at both 25 and 37 °C, while the control gel (CHP407_15%w/v) and the
sample loaded with MBG_Cu 2%_SD retained their injectability. This
different behaviour can be ascribed to the higher viscosity and faster gel
formation and development of CHP407_15%w/v_SG sol-gel systems
compared to both MBG_Cu 2%_SD-loaded hydrogel and not-loaded
CHP407_15%w/v, as also suggested by tube inverting and gelation time
tests results.
The tested range of needle diameters (G22-G14) and gel storage
conditions (5, 25 and 37 °C) open the way to different potential appli-
cations of the designed hybrid sol-gel systems, such as intramuscular
injection (suggested needles in the range G21-G23), intra-bone injec-
tion (G13 needle is usually used for percutaneous vertebroplasty), to-
pical application on infected skin wounds (no particular needs to be
addressed).
3.3.3. Hydrogel stability and swelling
CHP407-based gels with a 15% w/v PEU concentration and loaded
with MBG_Cu 2%_SG and MBG_Cu 2%_SD particles at 20mg/mL were
characterized in terms of their swelling behaviour and stability in
aqueous environment in the presence of a buffer solution at pH 7.4 at
37 °C. Not-loaded CHP407-based gels with the same polymer con-
centration (CHP407_15%w/v) were also analyzed to assess the influ-
ence of particle loading on these properties. Fig. 8 reports the percen-
tage of swelling (Fig. 8A) and dissolution (Fig. 8B) of loaded and not-
loaded CHP407 gels at different time points, evaluated according to the
equations defined in paragraph 2.6.4.
Up to 24 h of incubation time, loaded gels showed a degree of
swelling similar to not-loaded CHP407_15%w/v gels (approx. 4.5%).
However, after 3 days incubation, loaded gels showed a significant
decrease in swelling percentage compared to not-loaded CHP407_15%
w/v (swelling percentage of 11.0 ± 0.3%), suggesting that dissolution
phenomena became more relevant than swelling for Cu-MBG loaded
gels (8.6 ± 0.3% and 6.4 ± 0.6% for CHP407_15%w/v_SD and
CHP407_15%w/v_SG, respectively). On day 7, CHP407_15%w/v_SG
and CHP407_15%w/v_SD showed negative swelling data, which means
that dissolution had totally overstepped swelling phenomena. Indeed,
Table 2
Injectability of CHP407_15%w/v sol-gel systems loaded and not-loaded with MBG_Cu 2%_SG and MBG_Cu 2%_SD at 20mg/mL concentration evaluated at different temperatures (5, 25
and 37 °C) through different needles (G22, G18, G14). Codes: X – not injectable; V – injectable; dint – internal diameter.
CHP407_15%w/v CHP407_15%w/v_SG CHP407_15%w/v_SD
5 °C G22 (dint= 0.64mm) V V V
G18 (dint= 1.02mm) V V V
G14 (dint= 1.63mm) V V V
25 °C G22 (dint= 0.64mm) X X X
G18 (dint= 1.02mm) V X V
G14 (dint= 1.63mm) V V V
37 °C G22 (dint= 0.64mm) X X X
G18 (dint= 1.02mm) V X V
G14 (dint= 1.63mm) V V V
Fig. 8. (A) Buffer (pH 7.4) absorption and (B) dissolution percentages as a function of
time of CHP407_15%w/v, CHP407_15%w/v_SG and CHP407_15%w/v_SD gels.
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loaded gels were almost completely dissolved after 7 days of incubation
(dissolution of 65.4 ± 2.8% and 76.0 ± 2.4% for CHP407_15%w/
v_SD and CHP407_15%w/v_SG, respectively), while the not-loaded
CHP407_15%w/v gels showed only a partial dissolution of
21.1 ± 0.6%. After 14 days of incubation in aqueous environment at
37 °C, the swelling percentage of CHP407_15%w/v gels slightly de-
creased with respect to 7 days (12.3 ± 0.2% vs 9.6 ± 0.6%, not sig-
nificant difference), suggesting that, differently from loaded samples,
dissolution started to prevail over absorption after 7 days incubation
time. The dissolution degree increased over time for all the analyzed
samples and it was significantly more pronounced in MBG particles-
loaded gels with respect to not-loaded CHP407_15%w/v at each time
points, suggesting that particle incorporation significantly affects the
stability of the resulting hybrid systems in an aqueous environment,
irrespective of their morphological features.
The morphology of hybrid hydrogels was also characterized through
FE-SEM observation (Fig. 9) before soaking in Tris HCl buffer (time 0)
and at different time points (24 h and 7 days). No images were recorded
at 14 days incubation time as the hybrid samples were completely
dissolved at this time point, as shown also in Fig. 8. FE-SEM images of
both CHP407_15%w/v_SG and CHP407_15%w/v_SD at time 0 (prior to
incubation) revealed a good and homogeneous particle dispersion into
the hydrogel network with small aggregates composed by few particles
(from 2 to 5 particles). FE-SEM analysis showed no significant changes
in the morphology of the hybrid systems after 24 h and 7 days immer-
sion in Tris HCl solution. Furthermore, the size of MBG particles em-
bedded into the hydrogels was not significantly affected by the im-
mersion into an aqueous medium.
3.3.4. Evaluation of Cu ion release from CHP407 hydrogels loaded with Cu-
MBGs
Release properties of Cu-MBGs embedded in CHP407 hydrogel have
been studied by soaking the hybrid gels in Tris HCl previously equili-
brated at 37 °C. At predefined time steps (3 h, 24 h, 3 days, 7 days,
14 days) the supernatants were collected and Cu2+ ion concentration
measured. Fig. 10 reports the release profiles obtained for CHP407_15%
w/v_SG and CHP407_15%w/v_SD. At variance with the release beha-
viour of MBG_Cu 2%_SG particles, where a pronounced initial burst
effect was observed, CHP407_15%w/v_SG showed a sustained release of
Cu2+ species with a slower kinetics. These data confirm that particles
are accessible to the soaking medium, although incorporated into the
hydrogel, and able to deliver Cu2+ species through ion-exchange re-
actions. Copper was successfully released also from CHP407_15%w/
v_SD, although the final released concentration after 14 days was lower
than that measured for CHP407_15%w/v_SG, in analogy with the re-
leased concentrations from MBG particles alone. This seems to suggest
that incorporated particles retain their release properties and reactivity
despite their embedding into the thermosensitive sol-gel systems, which
is a crucial aspect in view of the final application. Furthermore, the
amounts of copper released from the hybrid formulations, normalized
Fig. 9. FE-SEM images of freeze-dried samples of CHP407_15%w/v_SG (on the left) and CHP407_15%w/v_SD (on the right) before soaking in Tris HCl medium (A), after 24 h (B) and
7 days (C) of incubation.
Fig. 10. Cu2+ release profiles in Tris HCl at 37 °C from CHP407_15%w/v_SG and
CHP407_15%w/v_SD.
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on the amount of releasing powder, are comparable to those obtained
from Cu-MBGs alone.
4. Conclusions
In this work, a novel platform of hybrid injectable formulations for
in situ delivery of therapeutic ions was developed by incorporating
copper containing MBG nano- or microspheres into a thermosensitive
polyurethane-based hydrogel, able to concentrate and maintain the
multifunctional carriers at the pathological site and to guarantee in situ
and prolonged release of ions/drugs. The composition of the injectable
hydrogel was tailored in order to improve gelation kinetics and stability
in aqueous environment.
Irrespective of the embedded Cu-MBG size, the designed hybrid
formulations showed fast gelation in physiological conditions (a volume
of 1mL undergoes complete sol-to-gel transition within few minutes of
incubation at 37 °C) and injectability in a wide range of temperatures
through different needles (temperature range 5–37 °C, needles with
inner diameter in the range 0.6–1.6 mm). Moreover, although MBG
particle incorporation significantly affected the stability of the hybrid
hydrogels in aqueous environment, leading to a complete dissolution
after 14 days of incubation, the developed hybrid formulations showed
the ability to remain in situ for several days, thus allowing the release of
Cu2+ ions with a sustained and prolonged kinetics with respect to Cu-
MBG particles as such.
Hence, the herein designed and characterized hybrid platforms
show great potential as in situ injectable delivery systems of therapeutic
ions and/or drugs for the treatment of delayed bone regeneration and
wound healing.
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